Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

837 - The study of MIB-1 LI and CD-34 as a marker of proliferative activity and angiogenesis in different grades of meningioma


09 Oct 2016


Poster display


Harishkumar Bohra


Annals of Oncology (2016) 27 (6): 103-113. 10.1093/annonc/mdw367


H.R. Bohra

Author affiliations

  • Pathology, All India Institute Of Medical Sciences(AIIMS), 342005 - Jodhpur/IN


Abstract 837


Meningiomas comprise 24-30% of all tumours occurring in the central nervous system. Conventional morphologic criteria as studied in routine Hematoxylin and Eosin stained sections ( H and E) may not be accurate in grading and assessing prognosis in small stereotactic biopsy specimens. Thus, the need for objective methods for assessing tumour biology. Prolifereative index using MIB -1 labelling index is helpful in grading and prognosis of tumours. Angiogenesis is a key event in the spread of tumours and denotes a poor prognosis. Intratumoral microvessel density (MVD) helps in quantification of angiogenesis.


Paraffin blocks of 30 surgically resected cases, 10 each of Grade I, II and III meningiomas were reviewed. Tumours were graded and subtyped as per WHO criteria. Immunohistochemical staining was done for proliferative index with Ki-67 and for angiogenesis with CD 34 antibodies. Statistical analysis was performed using Mann – Whitney U test. p value of 


The male to female ratio overall was 1:1.The age of the patients ranged from 18-81 years. 73% of patients had raised intracranial pressure and 18.4% of patients presented with seizures. The mean +/- SD MIB-1 LI was 1.14 +/-0.84, 8.94 + /-2.73 and 35.62 +/-4.44 in grade I, II and III tumours respectively which was statistically significant. (p< 0.01). The mean +/- SD MVD was 49.67 +/- 22.35, 41.37 + /-7.45 and 47.86 +/- 10.77 respectively in grade I, II and III tumours respectively. was statistically non significant ( p > 0.05).


MIB-1 LI is an important complementary tool to accurately grade meningothelial tumours and assess tumour biology. Specific cycling endothelial markers along with CD 34 MVD could be used to assess the prognosis of these tumours.

Clinical trial identification

Not applicable in this study.

Legal entity responsible for the study

National Board of Examinations, New Delhi. Base Hospital, Delhi Cantt, New Delhi.


Base Hospital Delhi Cantt, New Delhi.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings